Results 171 to 180 of about 8,164,322 (359)
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Electronic data sources for drug utilization research and healthcare decision-making in Mexico. [PDF]
Santa-Ana-Tellez Y +7 more
europepmc +1 more source
Comprehensive drug utilization review in neonates: liposomal amphotericin B
Chirlie Silver, Sara E. Rostas
semanticscholar +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Care pathway in patients after myocardial infarction in Denmark - healthcare and drug utilization. [PDF]
Flege MM +7 more
europepmc +1 more source
Platform Development for Drug Discovery Utilizing Silkworm towards “Novel Industrial Revolution”
Kazuhisa Sekimizu, Kohji Itoh
openalex +2 more sources
Utilization, Spending, and Prices Trends for Anti-Epileptic Drugs (AEDS) in the U.S. Medicaid Programs: Empirical Data Analysis from 2010 to 2016 [PDF]
Xiaomeng Yue, JJ Guo
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source

